Anti-MERS-CoV ORF4a Polyclonal Antibody from ProteoGenix; catalogue ARO-A22268; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-MERS-CoV ORF4a Polyclonal Antibody – a powerful tool for researchers studying the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
This highly specific antibody targets the ORF4a protein, a key component of the MERS-CoV genome. By binding to ORF4a, this antibody can help researchers gain a better understanding of the virus and its mechanisms of infection.
One of the main applications of our Anti-MERS-CoV ORF4a Polyclonal Antibody is in diagnostic assays. Its high sensitivity and specificity make it an ideal candidate for detecting the presence of MERS-CoV in patient samples. This can aid in the early detection and management of MERS-CoV infections.
In addition, this antibody can also be used in immunofluorescence and immunohistochemistry experiments to visualize the localization of ORF4a within infected cells. This can provide valuable insights into the virus’s replication and pathogenesis.
Our Anti-MERS-CoV ORF4a Polyclonal Antibody has been extensively validated in various experimental models, including cell culture and animal studies. Its efficacy has been demonstrated in detecting MERS-CoV infection in both human and animal samples.
With its high specificity and sensitivity, this antibody is an essential tool for researchers studying MERS-CoV and its potential treatments. Its reliable performance and versatility make it a valuable addition to any biotech laboratory.
Don’t miss out on the opportunity to enhance your research with our Anti-MERS-CoV ORF4a Polyclonal Antibody. Place your order today and join the fight against this emerging viral threat.
ProteoGenix catalogue number ARO-A22268. For research use only.
Target: Non-structural protein ORF4a; ORF4a; ORF4a; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Non-structural protein ORF4a; ORF4a; ORF4a |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
